{"id":4086,"date":"2021-11-25T20:55:24","date_gmt":"2021-11-25T20:55:24","guid":{"rendered":"https:\/\/biotechsa.com\/2\/?p=4086"},"modified":"2026-03-10T13:01:20","modified_gmt":"2026-03-10T19:01:20","slug":"global-antibiotic-consumption-rates-have-increased-by-46-percent-since-2000","status":"publish","type":"post","link":"https:\/\/biotechsa.com\/2\/noticias\/global-antibiotic-consumption-rates-have-increased-by-46-percent-since-2000\/","title":{"rendered":"Global antibiotic consumption rates have increased by 46 percent since 2000"},"content":{"rendered":"\n
<\/span><\/div>

According to a new study recently shared by Medical Xpress, antibiotic consumption rates grew by 46% between 2000 and 2018. The study, published in Lancet Planetary Health by the Global Research on Antimicrobial Resistance (GRAM) Project, provides a comparative analysis of total antibiotic consumption rates in humans across 204 countries.\u00a0<\/p>\n

The overuse of antibiotics is a key driver of drug resistant infections, though little data can be found on antibiotic consumption. The GRAM Project used a \u201cnovel approach that deployed statistical modeling techniques, and incorporated multiple data sources and types, such as large-scale household surveys in low-and middle-income countries, pharmaceutical sales data, and antibiotic consumption data from the World Health Organization and the European Centre for Disease Prevention and Control.\u201d The study found high rates of antibiotic consumption in North America, Europe and the Middle East compared to low rates of consumption in sub-Saharan Africa and parts of Southeast Asia. Additionally, a 76% increase of antibiotic consumption was discovered in low and middle-income countries between 2000-2018.<\/p>\n

Professor Christiane Dolecek, the study’s lead author and GRAM scientific lead based at Oxford University states, “It is imperative to curb the unnecessary demand for antibiotics and combat antimicrobial resistance by improving drinking water and sanitation, vaccine coverage and the availability of rapid diagnostic testing, whilst also increasing access and stewardship of antibiotics when and where they are needed.\u201d Members of the GRAM Project hope that this platform and global effort of benchmarking antibiotic consumption will \u201chelp inform future interventions to improve antibiotic use and consumption.\u201d<\/p>\n

\n

\n

Click here to read the full article.<\/a><\/p>\n

\n

\n<\/div><\/div>

TRADUCCI\u00d3N DE GOOGLE:<\/span><\/strong><\/p>\n

\n<\/div><\/div>

Las tasas mundiales de consumo de antibi\u00f3ticos han aumentado en un 46 por ciento desde 2000<\/strong><\/h3>\n

<\/strong><\/p>\n

Seg\u00fan un nuevo estudio compartido recientemente por Medical Xpress, las tasas de consumo de antibi\u00f3ticos aumentaron en un 46% entre 2000 y 2018. El estudio, publicado en Lancet Planetary Health por el Proyecto Global Research on Antimicrobial Resistance (GRAM), proporciona un an\u00e1lisis comparativo del total de antibi\u00f3ticos tasas de consumo humano en 204 pa\u00edses.<\/p>\n

El uso excesivo de antibi\u00f3ticos es un factor clave de las infecciones resistentes a los medicamentos, aunque se pueden encontrar pocos datos sobre el consumo de antibi\u00f3ticos. El Proyecto GRAM utiliz\u00f3 un \u201cenfoque novedoso que implement\u00f3 t\u00e9cnicas de modelado estad\u00edstico e incorpor\u00f3 m\u00faltiples fuentes y tipos de datos, como encuestas de hogares a gran escala en pa\u00edses de ingresos bajos y medianos, datos de ventas farmac\u00e9uticas y datos de consumo de antibi\u00f3ticos de World Health Organizaci\u00f3n y el Centro Europeo para la Prevenci\u00f3n y el Control de Enfermedades \u201d. El estudio encontr\u00f3 altas tasas de consumo de antibi\u00f3ticos en Am\u00e9rica del Norte, Europa y Medio Oriente en comparaci\u00f3n con las bajas tasas de consumo en \u00c1frica subsahariana y partes del sudeste asi\u00e1tico. Adem\u00e1s, se descubri\u00f3 un aumento del 76% en el consumo de antibi\u00f3ticos en pa\u00edses de ingresos bajos y medianos entre 2000-2018.<\/p>\n

La profesora Christiane Dolecek, autora principal del estudio y l\u00edder cient\u00edfica de GRAM con sede en la Universidad de Oxford, afirma: “Es imperativo frenar la demanda innecesaria de antibi\u00f3ticos y combatir la resistencia a los antimicrobianos mejorando el agua potable y el saneamiento, la cobertura de vacunas y la disponibilidad de pruebas de diagn\u00f3stico r\u00e1pido, al mismo tiempo que aumenta el acceso y la administraci\u00f3n de los antibi\u00f3ticos cuando y donde se necesitan “. Los miembros del Proyecto GRAM esperan que esta plataforma y el esfuerzo global de evaluaci\u00f3n comparativa del consumo de antibi\u00f3ticos \u201cayuden a informar futuras intervenciones para mejorar el uso y el consumo de antibi\u00f3ticos\u201d.<\/p>\n

\n

Click here to read the full article.<\/a><\/p>\n

 <\/p>\n

\n

\n<\/div><\/div><\/div><\/div><\/div>

\n\n